Clinical Trial Update: Evaluation of the PreCursor-M+® in CIN2

View source ↗

Summary

The document notes that a clinical trial evaluating PreCursor-M+® for cervical intraepithelial neoplasia grade 2 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• PreCursor-M+

Snippet

Sponsor: European Institute of Oncology | Conditions: Cervical Intraepithelial Neoplasia Grade 2 | Status: RECRUITING